Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 223Pancreatic Neoplasms 140Stomach Neoplasms 87Carcinoma, Hepatocellular 82Carcinoma, Non-Small-Cell Lung 64Esophageal Neoplasms 63Colonic Neoplasms 60Breast Neoplasms 52Rectal Neoplasms 50Ovarian Neoplasms 46Neoplasm Metastasis 41Lung Neoplasms 41Cholangiocarcinoma 41Neoplasms 39Prostatic Neoplasms 33Melanoma 33Liver Neoplasms 33Gastrointestinal Neoplasms 33Sarcoma 27Endometrial Neoplasms 27Carcinoma, Renal Cell 24Squamous Cell Carcinoma of Head and Neck 23Biliary Tract Neoplasms 23Urinary Bladder Neoplasms 21Uterine Cervical Neoplasms 19Esophageal Squamous Cell Carcinoma 19Head and Neck Neoplasms 16Adenocarcinoma Of Esophagus 16Small Cell Lung Carcinoma 15Gastrointestinal Stromal Tumors 15

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymus Neoplasms × Gastrointestinal × 30 days × Clear all
NCT06885697 2026-06-05

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
100 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡